Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETHOSUXIMIDE Cause Attention deficit/hyperactivity disorder? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Attention deficit/hyperactivity disorder have been filed in association with ETHOSUXIMIDE (ETHOSUXIMIDE). This represents 0.6% of all adverse event reports for ETHOSUXIMIDE.

8
Reports of Attention deficit/hyperactivity disorder with ETHOSUXIMIDE
0.6%
of all ETHOSUXIMIDE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Attention deficit/hyperactivity disorder From ETHOSUXIMIDE?

Of the 8 reports.

Is Attention deficit/hyperactivity disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ETHOSUXIMIDE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does ETHOSUXIMIDE Cause?

Drug ineffective (342) Seizure (160) Off label use (116) Treatment failure (102) Multiple-drug resistance (84) Generalised tonic-clonic seizure (81) Somnolence (72) Fatigue (63) Epilepsy (58) Ataxia (57)

What Other Drugs Cause Attention deficit/hyperactivity disorder?

METHYLPHENIDATE (127) VALPROATE (101) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (88) LAMOTRIGINE (88) SODIUM OXYBATE (85) PAROXETINE (68) FINASTERIDE (65) QUETIAPINE (62) ARIPIPRAZOLE (59) FLUOXETINE (56)

Which ETHOSUXIMIDE Alternatives Have Lower Attention deficit/hyperactivity disorder Risk?

ETHOSUXIMIDE vs ETHYL ICOSAPENTATE ETHOSUXIMIDE vs ETHYL LOFLAZEPATE ETHOSUXIMIDE vs ETHYLENE GLYCOL ETHOSUXIMIDE vs ETIFOXINE ETHOSUXIMIDE vs ETIZOLAM

Related Pages

ETHOSUXIMIDE Full Profile All Attention deficit/hyperactivity disorder Reports All Drugs Causing Attention deficit/hyperactivity disorder ETHOSUXIMIDE Demographics